IL2 and tuberculosis: Similarly, Picostim (similar to HMBPP except one carbon difference)/IL-2 administration induced activation and expansion of effector Vγ9Vδ2 T cells during both the acute and chronic phases of SHIV infection and also increased resistance to tuberculosis in macaques (131), supporting a rationale to explore Vγ9Vδ2 T cell-targeting as treatment of drug-resistant tuberculosis or HIV-associated tuberculosis.